image: Image Caption: Overview of lncRNAs summarized in this study.
Credit: GAD
A new review article highlights the powerful influence of long non-coding RNAs (lncRNAs) in regulating natural killer (NK) cells, revealing promising opportunities to enhance immune responses and improve treatment strategies across multiple diseases.
The article emphasizes how lncRNAs, once considered non-functional, are now recognized as key regulators of gene expression and essential drivers of immune activity. Their role in controlling the behavior of NK cells, a critical component of the innate immune system, is particularly significant. These cells are responsible for identifying and eliminating infected or abnormal cells through cytotoxic activity and coordinated immune signaling.
A central theme is the ability of lncRNAs to influence every stage of NK cell function, including development, differentiation, activation, recruitment, and cytotoxic performance. Through mechanisms such as epigenetic regulation, metabolic control, and interactions with other RNA molecules, lncRNAs enable precise and adaptable immune responses.
The article also explores how lncRNAs shape the tumor microenvironment, affecting how immune cells interact with cancer cells. By influencing immune cell infiltration and communication, these molecules can either support or hinder the body’s ability to fight disease. This highlights their importance in determining disease progression and therapeutic outcomes.
Another key insight is the role of lncRNAs in regulating the killing function of NK cells. By controlling the production of molecules involved in cell destruction, they directly impact the efficiency of immune defense. In addition, their involvement in metabolic pathways ensures that NK cells have the energy required for sustained activity.
The findings also point to the growing potential of targeting lncRNAs in therapeutic strategies. Because they regulate multiple biological pathways simultaneously, they present valuable opportunities for developing more effective and personalized treatments, particularly when combined with immunotherapy approaches.
Overall, this review provides a comprehensive overview of how lncRNAs orchestrate immune regulation through NK cells. By revealing these complex interactions, it opens new directions for advancing treatments in cancer and other diseases.
# # # # # #
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 8.4 |Impact Factor: 9.4
# # # # # #
More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available online in ScienceDirect (https://www.sciencedirect.com/journal/genes-and-diseases).
Submissions to Genes & Diseases may be made using Editorial Manager (https://www.editorialmanager.com/gendis/default.aspx).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.cn
X (formerly twitter): @GenesNDiseases (https://x.com/GenesNDiseases)
# # # # # #
Reference
Dan Zhang, Siqiao Wei, Qianqiu Wei, Zhansong Lin, Xiaoming Sun, The role of long non-coding RNAs in NK cell biology and diseases, Genes & Diseases, Volume 13, Issue 3, 2026, 101833, https://doi.org/10.1016/j.gendis.2025.101833